Q4 2021 Galmed Pharmaceuticals Ltd Earnings Call Transcript
Good day and welcome to the Galmed conference call to discuss financial results for the fourth quarter and year end 2021. Today's conference is being recorded. Before we begin, please note that we will be making certain forward-looking statement on today's call, including those regarding financial results, statements and focus regarding anticipated time lines and expectations with respect to our regulatory and clinical development programs, as well as other statements that relate to future events.
These statements are based on the beliefs and expectations of management as of today and actual results trends, time lines and projections relating to our financial position and projected development programs and pipeline could defer materially. We urge all investors to read carefully, the risk and uncertainties disclosed in our filings with the SEC including without limitation the risk under the heading risk factors described in our latest annual report on form 20F filed with the SEC. Galmed assumes no applications to update any forward-looking statements or information, which speak as of the respective
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |